Daily non-political popular news in brief.
Cell growth technology promises more successful drug development
09-18-2007 · EurekAlert!Scientists have developed unique technology to grow stem cells and other tissue in the laboratory in conditions similar to the way they grow in the human body. The technology, developed and patented by scientists at Durham University, UK, and its spin-out company ReInnervate Limited, is a plastic scaffold which allows cells to be grown in a more realistic three-dimensional form compared to the traditional flat surface of a Petri dish.
Read more »
Keywords: cell, growth, technology, promises, successful, drug, development, promise
« Previous | Next »
Similar news on "Cell growth technology promises more successful drug development":
- Propane fuel cell passes muster at Exit Glacier Nature Center
11-10-2006 · EurekAlert!
The Alaska Energy Technology Development Laboratory at the University of Alaska Fairbanks recently announced a successful field test of a prototype propane fuel cell.
Similar news · Read more »
- Jefferson scientists find guardian gene's choices crucial to stopping cancer process
01-05-2007 · EurekAlert!
Scientists at the Kimmel Cancer Center at Thomas JeffersonUniversity have uncovered a novel pathway by which the anti-cancer gene p53 springs into action, protecting a damaged cell from becoming cancer. The gene can either halt the cell's growth or send it spiraling toward certain death. How this choice is made, the researchers say, could have implications for future strategies in chemotherapy drug development.
Similar news · Read more »
- DNA-damage test could aid drug development
05-14-2007 · EurekAlert!
Researchers from Massachusetts Institute of Technology and Whitehead Institute have developed a cell culture test for assessing a compound's genetic toxicity that may prove dramatically cheaper than existing animal tests. This assay would allow genetic toxicity to be examined far earlier in the drug development process, making it much more efficient.
Similar news · Read more »
- Support for chromosomal theory of cancer found in cancers' development of drug resistance
06-27-2007 · EurekAlert!
Most cancer researchers are convinced that cancer results from a handful of genetic mutations that kick a cell into uncontrolled growth. UC Berkeley genetics researcher Peter Duesberg disagrees, and finds support for his "chromosomal" theory of cancer in the development of drug resistance by many cancers. While his theory implies their is no magic bullet against cancer, it does provide ways to detect cancer at an early stage.
Similar news · Read more »
- St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory
10-18-2007 · EurekAlert!
Investigators at St. Jude Children's Research Hospital have identified the cell that gives rise to the eye cancer retinoblastoma, disproving a long-standing principle of nerve growth and development.
Similar news · Read more »
- A study by the MUHC and McGill University opens a new door to understanding cancer
08-09-2007 · EurekAlert!
An in-depth understanding of the mechanisms that trigger cancer cell growth is vital to the development of more targeted treatments for the disease. An article published in the Aug. 3 issue of Molecular Cell provides a key to these mechanisms that may prove crucial in the future. The paper is co-authored by Dr. Morag Park, director of the MUHC Molecular Oncology Group, and Dr. Kalle Gehring, head of the Nuclear Magnetic Resonance Laboratory of the McGill University biochemistry department.
Similar news · Read more »
- VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
02-12-2008 · EurekAlert!
New research by scientists at Schepens Eye Research Institute may help explain why the anticancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients. Institute scientists mimicked the drug's activity in mice and found that it damaged the cell lining that prevents fluid from leaking from the ventricle into the brain.
Similar news · Read more »
- Successful completion of AmerHis, the first switchboard in space
11-22-2006 · European Space Agency (ESA)
Today in Madrid, the European Space Agency, the Spanish Centre for Industrial Technology Development (Centro para el Desarrollo Tecnológico Industrial – CDTI) and Hispasat, a Spanish telecommunications satellite operator, signed an agreement marking the successful completion of the AmerHis system implementation.
Similar news · Read more »
- Signal protein shows promise for blocking tumor promoters in skin cells
11-03-2006 · EurekAlert!
A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
Similar news · Read more »
- Mutation improves memory, may lead to memory-enhancing pill
04-05-2007 · EurekAlert!
A mind-altering mutation in mice results in an enhanced long-term memory, researchers report in the April 6, 2007, issue of the journal Cell, published by Cell Press. These findings point to a potential target for the development of a drug to treat memory loss, according to the researchers.
Similar news · Read more »
